نتایج جستجو برای: st elevation myocardial infarction
تعداد نتایج: 308583 فیلتر نتایج به سال:
BACKGROUND Distal embolization during primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction may result in reduced myocardial perfusion, infarct extension, and impaired prognosis. METHODS AND RESULTS In a prospective randomized trial, we studied the effect of routine thrombectomy in 215 patients with ST-segment-elevation myocardial infarction lasting <12 hours...
Cite this article as: Özdamar Ü, Akboğa MK, Bayraktar MF, Özeke Ö. New Insights on the "DC Shock-Reperfusion" in ST Elevation Myocardial Infarction: Killing Two Birds with One Stone? Balkan Med J 2017;34:382-3 ©Copyright 2017 by Trakya University Faculty of Medicine / The Balkan Medical Journal published by Galenos Publishing House. New Insights on the “DC Shock-Reperfusion” in ST Elevation Myo...
This editorial refers to ‘One-year outcomes after a strategy using enoxaparin vs. unfractionated heparin in patients undergoing fibrinolysis for ST-segment elevation myocardial infarction: 1-year results of the ExTRACTTIMI 25 trial’, by D.A. Morrow et al., on page 2097 and ‘Relations between bleeding and outcomes in patients with ST-elevation myocardial infarction in the ExTRACT-TIMI 25 trial’,...
The prevalence of microvascular angina is estimated to be up to 30% of stable angina patients with nonobstructive coronary arteries. 19% of women presenting with acute coronary syndrome, 30% of women presenting with unstable angina, 9.1% of women with non-ST-elevation myocardial infarction and 10% of women with ST-elevation myocardial infarction were determined to have normal or non-obstructive...
Variation in practice regarding pretreatment with dual antiplatelet therapy for patients with non–ST elevation myocardial infarction. Background-—Despite guideline recommendations, a significant number of patients with non–ST elevation myocardial infarction (NSTEMI) do not receive dual antiplatelet therapy (DAPT) before angiography " pretreatment. " While there may be valid clinical reasons to ...
The clinical presentation of ischaemic heart disease includes stable and unstable angina pectoris, silent ischaemia, myocardial infarction, heart failure and sudden death [1]. For many years, unstable angina has been considered an intermediate syndrome between chronic stable angina and acute myocardial infarction. In recent years, its pathophysiology has been clarified and acute coronary syndro...
Background: During the COVID-19 pandemic, cardiovascular hospitalizations decreased and in-hospital mortality for ST-elevation myocardial infarction heart failure increased. However, limited research has been conducted on hospitalization rates disease (CVD) other than ischemic failure.
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید